quinapril has been researched along with Coronary Restenosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alpert, MA; Deftereos, S; Driva, M; Giannopoulos, G; Kaoukis, A; Kossyvakis, C; Lappos, S; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Rentoukas, I | 1 |
Hashizume, Y; Kurusu, T; Kuwata, M; Mochizuki, S; Onodera, T; Shimazu, Y; Takikawa, K; Taniguchi, I; Yamazaki, T; Yoshikawa, M | 1 |
Dohi, Y; Fujii, T; Gomyo, Y; Hirai, Y; Kohno, N; Matsuura, W; Mito, S; Okimoto, T; Otsuka, M; Yamamoto, H | 1 |
Abe, Y; Hirosaka, A; Hisa, S; Igarashi, M; Kijima, M; Komatsu, N; Maehara, K; Maruyama, Y; Mitsugi, M; Ohwada, T; Tsuda, T; Ujiie, Y; Yaoita, H | 1 |
Mancini, GB | 1 |
Gomyo, Y; Hayashi, Y; Imazu, M; Kohno, N; Okimoto, T; Sekiguchi, Y; Shimohara, Y; Sumii, K; Tadehara, F; Toyofuku, M; Yamamoto, H; Yanagihara, K | 1 |
Hayashi, Y; Hiyama, K; Imazu, M; Kohno, N; Sumii, K; Toyofyuku, M; Yamamoto, H | 1 |
Hayakawa, T; Imai, H; Kamiya, H; Kondo, J; Mabuchi, Y; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Tsuboi, H; Tsuzuki, M | 1 |
7 trial(s) available for quinapril and Coronary Restenosis
Article | Year |
---|---|
Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Apoptosis Regulatory Proteins; Coronary Angiography; Coronary Restenosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Quinapril; Signal Transduction; Stents; Tetrahydroisoquinolines; Treatment Outcome | 2010 |
Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Quinapril; Stents; Tetrahydroisoquinolines; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; Vasodilator Agents | 2004 |
Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Coronary Disease; Coronary Restenosis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Proportional Hazards Models; Quinapril; Risk Factors; Tetrahydroisoquinolines | 2004 |
Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cilostazol; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Perindopril; Platelet Aggregation Inhibitors; Quinapril; Stents; Tetrahydroisoquinolines; Tetrazoles | 2006 |
Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Isoquinolines; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Quinapril; Stents; Tetrahydroisoquinolines | 2001 |
Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Coronary Disease; Coronary Restenosis; Female; Gene Frequency; Genotype; Humans; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrahydroisoquinolines | 2002 |
Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Topics: Aged; Alleles; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Body Mass Index; Coronary Disease; Coronary Restenosis; Humans; Isoquinolines; Middle Aged; Peptidyl-Dipeptidase A; Prodrugs; Quinapril; Risk Factors; Smoking; Stents; Tetrahydroisoquinolines | 2002 |
1 other study(ies) available for quinapril and Coronary Restenosis
Article | Year |
---|---|
Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Coronary Restenosis; Endothelium, Vascular; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 2001 |